254 related articles for article (PubMed ID: 32123105)
21. Probing the stability of the SpCas9-DNA complex after cleavage.
Aldag P; Welzel F; Jakob L; Schmidbauer A; Rutkauskas M; Fettes F; Grohmann D; Seidel R
Nucleic Acids Res; 2021 Dec; 49(21):12411-12421. PubMed ID: 34792162
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
Mekler V; Minakhin L; Severinov K
Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
[TBL] [Abstract][Full Text] [Related]
23. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes.
Szczelkun MD; Tikhomirova MS; Sinkunas T; Gasiunas G; Karvelis T; Pschera P; Siksnys V; Seidel R
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9798-803. PubMed ID: 24912165
[TBL] [Abstract][Full Text] [Related]
24. R-loop formation and conformational activation mechanisms of Cas9.
Pacesa M; Loeff L; Querques I; Muckenfuss LM; Sawicka M; Jinek M
Nature; 2022 Sep; 609(7925):191-196. PubMed ID: 36002571
[TBL] [Abstract][Full Text] [Related]
25. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
26. RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.
Tambe A; East-Seletsky A; Knott GJ; Doudna JA; O'Connell MR
Cell Rep; 2018 Jul; 24(4):1025-1036. PubMed ID: 30044970
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas9 Structures and Mechanisms.
Jiang F; Doudna JA
Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks.
Cofsky JC; Karandur D; Huang CJ; Witte IP; Kuriyan J; Doudna JA
Elife; 2020 Jun; 9():. PubMed ID: 32519675
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment.
Xu X; Duan D; Chen SJ
Sci Rep; 2017 Mar; 7(1):143. PubMed ID: 28273945
[TBL] [Abstract][Full Text] [Related]
30. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
32. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
33. Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage.
Stella S; Alcón P; Montoya G
Nature; 2017 Jun; 546(7659):559-563. PubMed ID: 28562584
[TBL] [Abstract][Full Text] [Related]
34. Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance.
Babu K; Amrani N; Jiang W; Yogesha SD; Nguyen R; Qin PZ; Rajan R
Biochemistry; 2019 Apr; 58(14):1905-1917. PubMed ID: 30916546
[TBL] [Abstract][Full Text] [Related]
35. A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9.
Dagdas YS; Chen JS; Sternberg SH; Doudna JA; Yildiz A
Sci Adv; 2017 Aug; 3(8):eaao0027. PubMed ID: 28808686
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis.
Singh D; Wang Y; Mallon J; Yang O; Fei J; Poddar A; Ceylan D; Bailey S; Ha T
Nat Struct Mol Biol; 2018 Apr; 25(4):347-354. PubMed ID: 29622787
[TBL] [Abstract][Full Text] [Related]
37. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
[TBL] [Abstract][Full Text] [Related]
39. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
Donohoue PD; Pacesa M; Lau E; Vidal B; Irby MJ; Nyer DB; Rotstein T; Banh L; Toh MS; Gibson J; Kohrs B; Baek K; Owen ALG; Slorach EM; van Overbeek M; Fuller CK; May AP; Jinek M; Cameron P
Mol Cell; 2021 Sep; 81(17):3637-3649.e5. PubMed ID: 34478654
[TBL] [Abstract][Full Text] [Related]
40. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
